AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 117 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $25,727,863 | -29.5% | 559,423 | -12.0% | 0.01% | -28.6% |
Q2 2023 | $36,518,910 | +50.0% | 635,443 | -2.1% | 0.01% | +40.0% |
Q1 2023 | $24,346,051 | +98.4% | 649,228 | +48.2% | 0.01% | +66.7% |
Q4 2022 | $12,271,276 | +5.2% | 437,947 | +5.5% | 0.00% | 0.0% |
Q3 2022 | $11,666,000 | -19.2% | 415,117 | -0.0% | 0.00% | 0.0% |
Q2 2022 | $14,442,000 | -0.5% | 415,143 | +2.7% | 0.00% | 0.0% |
Q1 2022 | $14,509,000 | +47.6% | 404,142 | -4.2% | 0.00% | +50.0% |
Q4 2021 | $9,828,000 | +22.1% | 421,951 | -0.3% | 0.00% | +100.0% |
Q3 2021 | $8,048,000 | -7.9% | 423,385 | -2.4% | 0.00% | -50.0% |
Q2 2021 | $8,742,000 | +3.6% | 433,603 | -5.8% | 0.00% | 0.0% |
Q1 2021 | $8,435,000 | -14.3% | 460,410 | -5.9% | 0.00% | 0.0% |
Q4 2020 | $9,841,000 | +2.7% | 489,320 | -4.2% | 0.00% | 0.0% |
Q3 2020 | $9,580,000 | -18.2% | 510,977 | -2.0% | 0.00% | -33.3% |
Q2 2020 | $11,717,000 | +57.7% | 521,635 | +4.2% | 0.00% | +50.0% |
Q1 2020 | $7,428,000 | -22.3% | 500,479 | +1.0% | 0.00% | 0.0% |
Q4 2019 | $9,562,000 | -9.5% | 495,667 | -7.0% | 0.00% | -33.3% |
Q3 2019 | $10,564,000 | +4.3% | 532,702 | +11.0% | 0.00% | +50.0% |
Q2 2019 | $10,133,000 | +4.7% | 480,049 | +1.3% | 0.00% | 0.0% |
Q1 2019 | $9,679,000 | +2.7% | 473,789 | +0.1% | 0.00% | -33.3% |
Q4 2018 | $9,422,000 | +1.9% | 473,437 | -1.5% | 0.00% | +50.0% |
Q3 2018 | $9,243,000 | +33.4% | 480,430 | +5.8% | 0.00% | 0.0% |
Q2 2018 | $6,930,000 | -20.9% | 454,100 | -2.8% | 0.00% | 0.0% |
Q1 2018 | $8,763,000 | -3.0% | 467,355 | -0.4% | 0.00% | 0.0% |
Q4 2017 | $9,032,000 | +5.4% | 469,432 | -2.1% | 0.00% | 0.0% |
Q3 2017 | $8,570,000 | -1.2% | 479,618 | -1.3% | 0.00% | 0.0% |
Q2 2017 | $8,675,000 | +25.7% | 485,706 | +2.0% | 0.00% | 0.0% |
Q1 2017 | $6,903,000 | -16.6% | 476,034 | +5.9% | 0.00% | -33.3% |
Q4 2016 | $8,279,000 | -0.7% | 449,463 | +2.3% | 0.00% | 0.0% |
Q3 2016 | $8,336,000 | +17.3% | 439,397 | -0.3% | 0.00% | +50.0% |
Q2 2016 | $7,106,000 | +53.6% | 440,796 | +14.3% | 0.00% | 0.0% |
Q1 2016 | $4,627,000 | -13.8% | 385,647 | +2.3% | 0.00% | 0.0% |
Q4 2015 | $5,365,000 | +35.6% | 376,997 | +11.4% | 0.00% | +100.0% |
Q3 2015 | $3,957,000 | +84.8% | 338,495 | +178.0% | 0.00% | 0.0% |
Q2 2015 | $2,141,000 | +51.8% | 121,749 | +29.2% | 0.00% | – |
Q1 2015 | $1,410,000 | +28.2% | 94,227 | -0.5% | 0.00% | – |
Q4 2014 | $1,100,000 | +324.7% | 94,728 | +326.5% | 0.00% | – |
Q3 2014 | $259,000 | – | 22,208 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alambic Investment Management, L.P. | 29,423 | $583,000 | 0.44% |
Matarin Capital Management, LLC | 223,184 | $4,426,000 | 0.34% |
Summit Global Investments | 42,725 | $847,000 | 0.10% |
FEDERATED HERMES, INC. | 1,747,921 | $34,661,000 | 0.08% |
ROTHSCHILD & CO ASSET MANAGEMENT US INC. | 347,307 | $6,887,000 | 0.08% |
MARSHALL WACE, LLP | 413,293 | $8,196,000 | 0.06% |
BOSTON ADVISORS LLC | 42,365 | $840,000 | 0.04% |
MARTINGALE ASSET MANAGEMENT L P | 214,444 | $4,254,000 | 0.04% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 177,321 | $3,516,000 | 0.04% |
SILVERCREST ASSET MANAGEMENT GROUP LLC | 231,041 | $4,582,000 | 0.04% |